Advanta bioKEMIX and Resolkem Form Joint Venture t...
Category : Licensing/Collaboration Deal 25 June 2026Advanta bioKEMIX Expands Manufacturing Presence Through New Partnership Advanta bioKEMIX, the Ind...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Ascletis Receives FDA Clearance to Begin Phase I S...
Category : Clinical Trial Update 25 June 2026Ascletis Advances New Obesity Treatment Candidate Into Clinical Development Ascletis Pharma has...
Helus Pharma Reports Strong Enrollment Progress in...
Category : Clinical Trial Update 25 June 2026APPROACH Phase 3 Study Crosses 86% Enrollment Milestone Helus Pharma has announced that patient...
MoonLake Reports Strong One-Year Phase 3 Results f...
Category : Clinical Trial Update 24 June 2026MoonLake Immunotherapeutics has announced positive Week 52 results from its Phase 3 VELA-1 and VELA-...
CureGene Doses First Patient in US Pivotal Trial o...
Category : Clinical Trial Update 24 June 2026CureGene Pharmaceutical has announced that the first participant has been successfully dosed in the...
Latest Newsletter Post
-
Helus Pharma Reports Strong Enrollm..
25 June 2026
-
Ascletis Receives FDA Clearance to..
25 June 2026
-
Advanta bioKEMIX and Resolkem Form..
25 June 2026
-
Agomab Unveils Phase 2b Study Desig..
24 June 2026
-
CureGene Doses First Patient in US..
24 June 2026
